ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - ondansetron as hydrochloride dihydrate - תמיסה להזרקה - ondansetron as hydrochloride dihydrate 2 mg/ml - ondansetron - ondansetron - adults: odnatron is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. odnatron is indicated for the prevention and treatment of post-operative nausea and vomiting (ponv).paediatric population: odantron is indicated for the management of chemotherapy-induced nausea and vomiting (cinv) in children aged ?6 months, and for the prevention and treatment of ponv in children aged ?2 years.

ישראל - עברית - Ministry of Health

perrigo israel pharmaceuticals ltd - granisetron as hydrochloride - solution for injection - granisetron - for the treatment of nausea and vomiting associated with antineoplastic therapy.

ישראל - עברית - Ministry of Health

padagis israel agencies ltd, israel - granisetron as hydrochloride - טבליה - granisetron as hydrochloride 1 mg - granisetron - granisetron - prevention of nausea and vomiting induced by cytostatic therapy.

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - granisetron as hydrochloride 3 mg / 3 ml - solution for infusion - granisetron - for the prevention and control of nausea and vomiting induced by cytostatic therapy (chemotherapy and radiotherapy).

ישראל - עברית - Ministry of Health

rafa laboratories ltd - palonosetron as hydrochloride - תמיסה להזרקה - palonosetron as hydrochloride 0.25 mg/vial - palonosetron - palonosetron - prevention of chemotherapy - induced nausea and vomiting (cinv).

ישראל - עברית - Ministry of Health

rafa laboratories ltd - palonosetron as hydrochloride - תמיסה להזרקה - palonosetron as hydrochloride 0.25 mg/vial - palonosetron - palonosetron - prevention of chemotherapy - induced nausea and vomiting (cinv).

ישראל - עברית - Ministry of Health

teva pharmaceutical indust.ltd - palonosetron as hydrochloride 0.05 mg / 1 ml - solution for injection - palonosetron - prevention of chemotherapy - induced nausea and vomiting (cinv).

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - aprepitant - קפסולות - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - aprepitant - קפסולות - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

ישראל - עברית - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - aprepitant - קפסולות - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.